Clinical Trial Update: Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating TU7710 in warfarin-anticoagulated healthy male subjects; conditions listed include Hemophilia A and Hemophilia B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• TU7710

Snippet

Sponsor: TiumBio Co., Ltd. | Conditions: Hemophilia a, Hemophilia B | Phase 1 | Status: COMPLETED